Agent Claire enables clinicians to act faster, reduce risk, and improve operational performance.
san francisco, April 28, 2026 /PRNewswire/ — Velana Health®a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), announced the release of a new artificial intelligence (AI) agent that assists clinicians in the complex and time-consuming process of submitting data to MIPS, the merit-based incentive payment system associated with Medicare reimbursement. Agent Claire accelerates reporting while reducing risk and improving performance. Now available in the Quality Measurement Dashboard application for eligible members of the American Academy of Ophthalmology (Academy) IRIS® Registry (Intelligent Research in Sight).
Claire integrates data and provides actionable insights so clinicians can efficiently meet MIPS requirements and maximize program performance.
The MIPS program incentivizes high-quality, cost-effective care by tying Medicare payments to clinician scores across performance categories. However, the program’s reporting requirements can be complex, and frequent changes to MIPS regulations place a burden on healthcare practices to stay informed and compliant.
Agent Claire leverages Verana Health’s extensive experience to guide medical practices through MIPS compliance and optimization. The AI agent’s advanced technical features are designed to help you accurately submit MIPS data and stay up to date with changes to reporting requirements, quality standards, performance thresholds, and other program details. Claire integrates data and provides actionable insights, allowing clinicians to efficiently meet MIPS requirements and maximize program performance while focusing on patient care.
Sujay Jadhav, CEO of Verana Health, said: “Building and incorporating AI agents into customer-facing applications not only provides significant productivity gains, but also a potential competitive advantage.” “The market is moving from disconnected automation to systems that think, predict, and act in real time. As a leader in real-world evidence innovation, we continue to expand and strengthen our capabilities for the life sciences community.”
“Our top priority is to guide the MIPS program toward meaningfully improving the quality of patient care while minimizing the burden on physicians so that they can perform at their highest levels. This work by Velana is an important step toward that latter goal,” said Dr. Stephen McLeod, CEO of the American Academy of Ophthalmology.
Verana Health is committed to enhancing and extending the capabilities of Agent Claire across a suite of Software-as-a-Service (SaaS)-based applications for life sciences organizations.
Increasing R&D productivity remains a top cost management priority, reflecting continued industry headwinds and rising costs. According to Deloitte, biopharma and medical technology leaders generally expect AI to help their organizations become more efficient in 2026, with 78% expecting AI to play a central role in driving major change. While the maturation of AI remains desirable for most organizations, the biggest advancement is in integrating AI tools into daily workflows to improve productivity.
Verana Health offers webinars. From rescue to resilience: Improving MIPS submission efficiency and compliancewe’ll be covering this topic in detail on Thursday, May 14th. Register now.
About Velana Health
Velana Health Inc.® is a digital health company that leverages physician expertise and artificial intelligence to unlock the true potential of real-world data and revolutionize patient care and clinical research. Get exclusive access to the world’s largest source of patient data in oncology, ophthalmology, neurology, and urology. Verana Health powers real-world evidence generation. Clinicians use these insights to improve the quality of care and quality of life for their patients, and life sciences companies use them to accelerate the development of new treatments. For more information, please visit www.veranahealth.com.
Source Velana Health
